Riviste scientifiche

When two people fancy each other their heart rates jump in harmony

New Scientist - 16 ore 2 min ago
In a blind date, couples whose heart rates become synchronised are more likely to be attracted to each other – but physical body language makes no difference

Marcus du Sautoy at NSLive: Can computers ever be truly creative?

New Scientist - Sab, 21/09/2019 - 13:00
Artificial intelligence is turbo charging the ability of machines to be creative. At New Scientist Live next month, mathematician Marcus du Sautoy will explain just how close we are to an AI Vincent van Gogh

Australia has a huge shortage of the medical isotope needed for scans

New Scientist - Sab, 21/09/2019 - 07:00
Australia is facing possibly its worst ever shortage of medical isotopes. These are used in diagnostics, meaning 10,000 people or more may miss out on vital diagnostic scans

UK academics are stockpiling lab equipment in case of a no-deal Brexit

New Scientist - Sab, 21/09/2019 - 07:00
The threat of a no-deal Brexit is causing staff at several universities in the UK to stockpile scientific equipment, including protective gloves and fly food

Podcast Extra: Absurd scientific advice

Nature - Sab, 21/09/2019 - 00:00

Nature, Published online: 21 September 2019; doi:10.1038/d41586-019-02855-3

Benjamin Thompson talks to XKCD’s Randall Munroe about his new book.

Prominent German neuroscientist committed misconduct in ‘brain-reading’ research

Nature - Sab, 21/09/2019 - 00:00

Nature, Published online: 21 September 2019; doi:10.1038/d41586-019-02862-4

German funding agency imposes strict sanctions on Niels Birbaumer, whose studies it says contained incomplete data — but Birbaumer stands by his results.

[Editorial] iHuman: a futuristic vision for the human experience

The Lancet - Sab, 21/09/2019 - 00:00
On Sept 10, 2019, the Royal Society published a report, iHuman: blurring lines between mind and machine, which presents a vision for how emerging neural interface technologies (NITs) could transform the future of medicine by the use of invasive and non-invasive neural devices that inter-relate with the central and peripheral nervous system. The report recognises potential ethical, sociopolitical, and commercial concerns that might be introduced.

[Editorial] Childhood cancer: unequal progress

The Lancet - Sab, 21/09/2019 - 00:00
September is Childhood Cancer Awareness Month. Each year more than 300 000 children younger than 19 years are diagnosed with cancer worldwide. Numbers of deaths have been steadily increasing mostly because of new cases in low-income and middle-income countries (LMICs).

[Editorial] The mental health imperative of children in conflict

The Lancet - Sab, 21/09/2019 - 00:00
On Sept 10, ahead of the UN General Assembly and a mental health in emergencies summit in the Netherlands (Oct 7–8), Save the Children released Road to Recovery: Responding to children's mental health in conflict. The report states that 142 million children are living in high-intensity conflict zones, with many more millions forced to abscond as refugees. More than 24 million children exposed to conflict today are likely to encounter mild to moderate mental health problems yet, as Save the Children rightly contends, the global response to mental health support continues to be regrettably inadequate.

[Comment] Public health in the Eastern Mediterranean Region: profound challenges, huge opportunities

The Lancet - Sab, 21/09/2019 - 00:00
When I became WHO's Regional Director for the Eastern Mediterranean in May, 2018, I felt honoured but slightly anxious. The WHO Regional Office for the Eastern Mediterranean serves 21 member states and Palestine (West Bank and Gaza Strip) with a population of more than 600 million. The region faces many challenges, including health and humanitarian emergencies on an unprecedented scale. However, I believe I am well placed to help tackle these challenges. My background as a family physician and hospital director has shown me the value of effective organisation, collaboration, and leadership with the focus always on helping each patient and their family.

[Comment] Offline: Transcending the guilt of global health

The Lancet - Sab, 21/09/2019 - 00:00
Any western medical institution more than a century old and which claims to stand for peace and justice has to confront a painful truth—that its success was built on the savage legacy of colonialism. Perhaps we deal with uncomfortable pasts by burying them, excusing them, or atoning for them. The Lancet, for example, is a colonial-era institution. Its editors today must be exquisitely sensitive to the ethics of memory. How easy it is for us to pronounce on what others should do from our position of advantage.

[World Report] Blood transfusion in Kenya faces an uncertain future

The Lancet - Sab, 21/09/2019 - 00:00
By the end of September, 2019, PEPFAR will stop supporting blood transfusion in Kenya, with no clear plan for the future. Paul Adepoju reports.

[Perspectives] Food as spectacle

The Lancet - Sab, 21/09/2019 - 00:00
There were long queues for the Christian Dior: Designer of Dreams when I went to London's Victoria & Albert Museum (V&A), but none for the FOOD: Bigger than the Plate exhibition. I went to the latter out of choice, I should declare. Both are large exhibitions but the contrast and similarities are intriguing: glamour versus the mundane; the elision of reality and fantasy; the application of not dissimilar marketing techniques; the effects of technology; the hidden labour force alongside celebrities; and more.

[Perspectives] Physicians, oaths, and vampires

The Lancet - Sab, 21/09/2019 - 00:00
In a provocative study titled “Does the Hippocratic Oath promote burnout?”, more than 2600 physicians were asked whether putting patient needs before their own, as required by their oath, heightened the danger of burnout. The results were mixed: roughly half believed that it did not and half were unsure or thought that it did. These findings confront one of the most cherished tenets of medicine, that doctors must put their pledge to their patients above everything else: their time, compensation, families, and even their own health and wellbeing.

[Perspectives] Dementia: towards a new republic of hope

The Lancet - Sab, 21/09/2019 - 00:00
“You have dementia.” Dreaded words that physicians hate to deliver and individuals wish never to personally receive. Dementia is typically regarded as a death sentence, a disease without a cure, a long slow deterioration, increasing dependency, and a loss of hope. But framing dementia in this way only adds to the fear and stigma surrounding this disease. One of us (BL) has spent over 30 years of clinical practice ruling out all other possibilities before telling a patient they have dementia. The other one of us (DW), partnered her mother, Alice, through a long dementia journey, during which Alice would often ask “Where am I? Why am I here?” Together, we trace some of the social origins of dementia's stigma and offer a way to restore hope that is independent of whether a cure is on the horizon or not.

[Obituary] Keerti Vandravan Shah

The Lancet - Sab, 21/09/2019 - 00:00
Virologist who confirmed the link between human papillomavirus and cervical cancer. Born in Ranpur, India, on Nov 2, 1928, he died following kidney failure in Ponce Inlet, FL, USA, on July 21, 2019, aged 90 years.

[Correspondence] Women's rights will drive universal health coverage

The Lancet - Sab, 21/09/2019 - 00:00
We support Simon Wright and Refiloe Mabjeane,1 who wrote on behalf of the Civil Society Engagement Mechanism for UHC2030, calling for a “radically different approach” to the UN high-level meeting on universal health coverage (UHC) on Sept 23, 2019. However, a radically different approach means prioritising gender equality and girls and women's health and rights in UHC, and this includes the health workforce.

[Correspondence] Analysis of the RIMDAMAL trial

The Lancet - Sab, 21/09/2019 - 00:00
The results of the RIMDAMAL trial in Burkina Faso, reported by Brian Foy and colleagues,1 show that repeated mass treatment with ivermectin can reduce the incidence of malaria in children aged 5 years or younger, with no serious adverse effects.

[Correspondence] Analysis of the RIMDAMAL trial – Authors' reply

The Lancet - Sab, 21/09/2019 - 00:00
We thank John Bradley and colleagues1 for their inquiry into our results and conclusions. Our study design of a few clusters (a total of eight were randomly assigned to the control or intervention group) was necessitated by the RIMDAMAL trial being a modestly funded pilot trial on ivermectin efficacy and safety.2 Furthermore, because we hypothesised that the ivermectin treatment would most affect clinical malaria incidence in this population living in a hyperendemic area, frequent measures of malaria incidence by study nurses were required.

[Correspondence] Environmental consequences of tobacco production and consumption

The Lancet - Sab, 21/09/2019 - 00:00
Vin Gupta and colleagues1 draw attention to the synergies between air pollution and tobacco exposure and suggest that it might be possible to leverage growing concern about the health effect of air quality to improve the global implementation of tobacco control measures. This is a welcome suggestion, but governments and other agencies should be encouraged to think even more widely when considering the environmental effects of tobacco production and consumption, as outlined in two reports.2,3